Syndicated Research Studies

Market Size & Trends The global downstream processing market size was estimated at USD 30.96 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 14.84% from 2023 to 2030. A rise in the utilization of downstream processing techniques for the development of COVID-19 vaccines is a significant factor driving the market. In March 2022, Rentschler Biopharma and Vetter released the launch of Xpert Alliance, a collaborative representation of their strategic relationship. The visualization is intended to "bring to life" this continuing collaboration and highlight its successful operation in offering effective solutions to customers' evolving and growing demands in the field of challenging biopharmaceuticals. Further, in April 2022, Bayer revealed that it is considering a collaboration wherein Ginkgo Bioworks will purchase Bayer's West Sacramento Biologics R&D location as well as its internal discovery and lead optimization platform. Th...

Downstream Processing Market Growth & Trends The global  downstream processing market  size is expected to reach USD 94.79 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 14.84% from 2023 to 2030.  The capacity requirements during the development of biologic drugs have changed over the past few years, wherein the demand for manufacturing high-volume products has shifted to developing small-volume, high-potency products. This creates new avenues for single-use technologies. A rise in the utilization of downstream processing techniques for the development of COVID-19 vaccines is a significant factor driving the market. The adoption of small-scale, single-use systems for process development and downstream processing is already high. Gather more insights about the market drivers, restrains and growth of the   Global Downstream Processing Market Thus, evolutionary changes are...

Downstream Processing Industry Overview The global downstream processing market size was estimated at USD 26.6 billion in 2021. and is expected to expand at a compound annual growth rate (CAGR) of 15.0% from 2022 to 2030. A rise in the utilization of downstream processing techniques for the development of COVID-19 vaccines is a significant factor driving the market. In March 2022, Rentschler Biopharma and Vetter released the launch of Xpert Alliance, a collaborative representation of their strategic relationship. The visualization is intended to “bring to life” this continuing collaboration and highlight its successful operation in offering effective solutions to customers’ evolving and growing demands in the field of challenging biopharmaceuticals. Gather more insights about the market drivers, restrains and growth of the Global Downstream Processing Market In April 2022, Bayer revealed that it is considering a collaboration wherein Ginkgo Bioworks will purchase...